ATE234631T1 - Immunisierungsverfahren in zwei schritten gegen pyramyxoviridae-viren unter verwendung abgeschwächter viraler stämme und preparation von proteinuntereinheiten - Google Patents

Immunisierungsverfahren in zwei schritten gegen pyramyxoviridae-viren unter verwendung abgeschwächter viraler stämme und preparation von proteinuntereinheiten

Info

Publication number
ATE234631T1
ATE234631T1 AT97930276T AT97930276T ATE234631T1 AT E234631 T1 ATE234631 T1 AT E234631T1 AT 97930276 T AT97930276 T AT 97930276T AT 97930276 T AT97930276 T AT 97930276T AT E234631 T1 ATE234631 T1 AT E234631T1
Authority
AT
Austria
Prior art keywords
rsv
piv
viruses
pyramyxoviridae
preparation
Prior art date
Application number
AT97930276T
Other languages
English (en)
Inventor
Michel H Klein
George A Cates
Mary E Ewasyshyn
M Louise Herlocher
H F Maassab
Original Assignee
Aventis Pasteur
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur, Univ Michigan filed Critical Aventis Pasteur
Application granted granted Critical
Publication of ATE234631T1 publication Critical patent/ATE234631T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97930276T 1996-07-12 1997-07-11 Immunisierungsverfahren in zwei schritten gegen pyramyxoviridae-viren unter verwendung abgeschwächter viraler stämme und preparation von proteinuntereinheiten ATE234631T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67920696A 1996-07-12 1996-07-12
PCT/CA1997/000499 WO1998002180A1 (en) 1996-07-12 1997-07-11 Two-step immunization procedure against the pyramyxoviridae family of viruses using attenuated viral strains and subunit protein preparation

Publications (1)

Publication Number Publication Date
ATE234631T1 true ATE234631T1 (de) 2003-04-15

Family

ID=24725990

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97930276T ATE234631T1 (de) 1996-07-12 1997-07-11 Immunisierungsverfahren in zwei schritten gegen pyramyxoviridae-viren unter verwendung abgeschwächter viraler stämme und preparation von proteinuntereinheiten

Country Status (7)

Country Link
US (1) US20030049276A1 (de)
EP (1) EP0936921B1 (de)
AT (1) ATE234631T1 (de)
AU (1) AU3431397A (de)
CA (1) CA2260107A1 (de)
DE (1) DE69720024D1 (de)
WO (1) WO1998002180A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077514A (en) * 1996-04-04 2000-06-20 The Regents Of The University Of Michigan Attenuated respiratory syncytial virus
AU2438597A (en) * 1996-04-04 1997-10-29 Regents Of The University Of Michigan, The Attenuated respiratory syncytial virus
AU731777B2 (en) 1998-11-30 2001-04-05 Nihon Nohyaku Co., Ltd. Aniline derivative and process for producing the same
EP1854433B1 (de) * 1999-10-22 2010-05-12 FSI Acquisition Sub, LLC Facettenarthroplastiegeräte
WO2001056602A2 (en) * 2000-02-02 2001-08-09 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Cd40 ligand adjuvant for respiratory syncytial virus
EP1409014B8 (de) * 2001-12-20 2007-04-25 Sanofi Pasteur Limited Immunogene zusammensetzungen die ein antigen und ein m protein des respiratorischen synzytialviruses enthalten
RU2612154C2 (ru) * 2009-12-23 2017-03-02 Санофи Пастер Способ культивирования адгезионных клеток

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01501357A (ja) * 1986-01-14 1989-05-18 ユニバ−シテイ・オブ・ノ−ス・カロライナ ヒト呼吸器系ウイルス用ワクチン
IL105456A (en) * 1992-04-21 1996-12-05 American Home Prod Vaccines of attenuated respiratory syncytial virus
ES2150493T5 (es) * 1993-05-25 2004-07-01 Wyeth Holdings Corporation Adyuvantes para vacunas contra el virus sincitico respiratorio.

Also Published As

Publication number Publication date
EP0936921B1 (de) 2003-03-19
AU3431397A (en) 1998-02-09
WO1998002180A1 (en) 1998-01-22
DE69720024D1 (de) 2003-04-24
EP0936921A1 (de) 1999-08-25
US20030049276A1 (en) 2003-03-13
CA2260107A1 (en) 1998-01-22

Similar Documents

Publication Publication Date Title
DK1296711T3 (da) HPV-E7 til behandling af humant papillomavirus
RU94042722A (ru) Химерный белок, ген, клетка, вектор, способ получения химерного белка, вакцина
DK0830141T3 (da) Forbedrede virusvacciner
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
CA2311492A1 (en) Vaccines with an ltb adjuvant
LV10203A (lv) Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts
DK1216053T3 (da) Influenzavaccine
DE69632235D1 (de) Newcastle-Krankheitsvirus-Kombinationsimpfstoff
BR9201848A (pt) Processo para a preparacao de particuals de virus para vacinas,vacina,e,processo para tratamento ou profilaxia de uma infeccao viral em um mamifero com necessidade dos mesmos
WO1997011093A3 (en) Parainfluenza virus glycoproteins and vaccines
FI905184A0 (fi) Kimeriska glykoproteiner som innehaoller immunogeniska delar av human parainfluensa-virus typ 3.
EA200000528A1 (ru) Способ получения вакцин для предупреждения патогенных эффектов, связанных с ретровирусной инфекцией
ATE234631T1 (de) Immunisierungsverfahren in zwei schritten gegen pyramyxoviridae-viren unter verwendung abgeschwächter viraler stämme und preparation von proteinuntereinheiten
CA2132374A1 (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
IT1252687B (it) Vaccino di poxvirus ricombinante del virus del morbillo
UA84667C2 (ru) Вакцина, направленная против инфекции, вызванной вирусом герпеса болезни марека
JP2000512263A (ja) インフルエンザワクチン
WO2019143712A8 (en) Induced common antibody response
WO2000012684A3 (en) Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus
DK0687181T3 (da) Metode til behandling af hepatitis C hos individer, som ikke responderer på interferon-behandling
IE830861L (en) Equine influenza vaccine.
WO2002047720A3 (en) Treatment and prevention of ebv infection and ebv-associated disorders
ES2055610T3 (es) Vacuna contra hrsv.
EP0247873A3 (de) Bacteriocine und Zubereitungen derselben für die antivirale Behandlung
KINOSHITA Studies on Inactivation of Rickettsia tsutsugamushi by Ultra-violet Irradiation I. Inactivation of Rickettsia tsutsugamushi by Ultra-violet Irradiation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties